Amarin Corp Plc\Uk financial data

Symbol
AMRN on Nasdaq
Industry
Pharmaceutical Preparations
Location
Spaces South Docklands, Block C, 77 Sir John Rogerson's Quay, Dublin 2, Ireland
State of incorporation
United Kingdom
Fiscal year end
December 31
Former names
AMARIN PHARMACEUTICALS PLC (to 7/13/2000), ETHICAL HOLDINGS PLC (to 1/28/1998)
Latest financial report
10-Q - Q3 2024 - Oct 30, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 302 % +12.4%
Quick Ratio 107 % +18.7%
Debt-to-equity 45.4 % -8.5%
Return On Equity -7.22 % +20.8%
Return On Assets -4.96 % +18.5%

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 411M shares +0.66%
Entity Public Float 485M USD -32.8%
Common Stock, Value, Issued 305M USD +0.95%
Weighted Average Number of Shares Outstanding, Basic 411M shares +0.67%
Weighted Average Number of Shares Outstanding, Diluted 411M shares +0.67%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 241M USD -25.3%
Research and Development Expense 20.7M USD -4.58%
Operating Income (Loss) -44.1M USD +39%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -29.7M USD +48.7%
Income Tax Expense (Benefit) 9.61M USD +620%
Net Income (Loss) Attributable to Parent -39.3M USD +25%
Earnings Per Share, Basic -0.1 USD/shares +16.7%
Earnings Per Share, Diluted -0.1 USD/shares +16.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 157M USD -42%
Accounts Receivable, after Allowance for Credit Loss, Current 113M USD -7.97%
Inventory, Net 224M USD -12%
Assets, Current 650M USD -9.38%
Property, Plant and Equipment, Net 24K USD -83.7%
Operating Lease, Right-of-Use Asset 7.98M USD -6.18%
Other Assets, Noncurrent 1.25M USD -10.4%
Assets 751M USD -10.5%
Accounts Payable, Current 40.5M USD -24.1%
Employee-related Liabilities, Current 18.9M USD -6.7%
Contract with Customer, Liability, Current 2.34M USD +6.46%
Liabilities, Current 202M USD -24.4%
Contract with Customer, Liability, Noncurrent 2.11M USD -83.4%
Operating Lease, Liability, Noncurrent 8.22M USD -8.42%
Other Liabilities, Noncurrent 9.47M USD +30.2%
Liabilities 219M USD -23.3%
Retained Earnings (Accumulated Deficit) -1.62B USD -2.49%
Stockholders' Equity Attributable to Parent 531M USD -3.94%
Liabilities and Equity 751M USD -10.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -12.6M USD -79.8%
Net Cash Provided by (Used in) Financing Activities -1.43M USD -492%
Net Cash Provided by (Used in) Investing Activities 28.7M USD
Common Stock, Shares, Issued 422M shares +1.02%
Common Stock, Par or Stated Value Per Share 0.5 GBP/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 14.7M USD
Deferred Tax Assets, Valuation Allowance 172M USD +3.88%
Deferred Tax Assets, Gross 176M USD +3.52%
Operating Lease, Liability 10.2M USD -6.42%
Lessee, Operating Lease, Liability, to be Paid 13.5M USD -11.2%
Property, Plant and Equipment, Gross 1.49M USD -55.4%
Operating Lease, Liability, Current 1.94M USD +2.22%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.56M USD +17.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.91M USD +1.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3.33M USD -23%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.97M USD -8.51%
Deferred Tax Assets, Operating Loss Carryforwards 154M USD +12.6%
Unrecognized Tax Benefits 18.7M USD -0.31%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.98M USD +0.82%
Additional Paid in Capital 1.91B USD +0.86%
Amortization of Intangible Assets 729K USD +3.85%
Deferred Tax Assets, Net of Valuation Allowance 4.52M USD -8.54%